Found: 9
Select item for more details and to access through your institution.
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 5, p. 1, doi. 10.1002/prp2.842
- By:
- Publication type:
- Article
Effect of Multiple Oral Doses of Linagliptin on the Steady-State Pharmacokinetics of a Combination Oral Contraceptive in Healthy Female Adults.
- Published in:
- Clinical Drug Investigation, 2011, v. 31, n. 9, p. 643, doi. 10.2165/11590240-000000000-00000
- By:
- Publication type:
- Article
Publisher Correction: Detector clothes for MRI: A wearable array receiver based on liquid metal in elastic tubes.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Detector clothes for MRI: A wearable array receiver based on liquid metal in elastic tubes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65634-5
- By:
- Publication type:
- Article
Pharmacokinetic Evaluation of Three Different Intramuscular Doses of Nandrolone Decanoate: Analysis of Serum and Urine Samples in Healthy Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 5, p. 2624, doi. 10.1210/jc.2004-1526
- By:
- Publication type:
- Article
Elastomer coils for wearable MR detection.
- Published in:
- Magnetic Resonance in Medicine, 2021, v. 85, n. 5, p. 2882, doi. 10.1002/mrm.28662
- By:
- Publication type:
- Article
The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 1, p. 39, doi. 10.1111/j.1365-2125.2011.03931.x
- By:
- Publication type:
- Article
An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 9, p. 950, doi. 10.1177/009127000104100904
- By:
- Publication type:
- Article
Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 6, p. 2420, doi. 10.1111/cts.13108
- By:
- Publication type:
- Article